Inhibition of NF-κB activity in breast cancer was also shown to induce apoptosis corresponding to the reduced phosphorylated NF-κB level and enhanced apoptosis in MDA-MB-231 cells treated with CB agonists in this study56. Here, NFKB1 is linked to breast carcinoma.